Company Filing History:
Years Active: 2019-2024
Title: Innovator Andreas Konrad – A Pioneer in Colorectal Cancer Detection
Introduction
Andreas Konrad, based in Erlangen, Germany, is a distinguished inventor known for his contributions to the field of medical diagnostics. With three patents to his name, he has significantly influenced the detection and understanding of colorectal cancer, showcasing his dedication to innovation in healthcare.
Latest Patents
Among his recent achievements are groundbreaking patents for methods and products aimed at detecting an increased risk or incidence of colorectal cancer. These inventions detail processes for determining the probability, risk, or incidence of colorectal cancer and its metastasis. Notably, his patented methods involve detecting the expression levels of key markers such as COL10A1 and MMP11 from various samples, including tissue samples from individuals currently diagnosed with cancer or those undergoing diagnostics.
Career Highlights
Andreas Konrad’s professional journey is closely linked with Siemens Healthcare Diagnostics GmbH, a leading company in the medical diagnostics sector. His work there not only enhances the capabilities of cancer detection but also supports the overarching goal of improving patient outcomes through innovative diagnostic techniques.
Collaborations
Throughout his career, Konrad has collaborated with notable figures in the field, including his coworkers Michael Stürzl and Roland S. Croner. These collaborations have further enriched his research and development efforts, leading to advancements that benefit the medical community and patients alike.
Conclusion
Andreas Konrad stands as a pivotal figure in the realm of colorectal cancer detection, exemplifying the spirit of innovation. His patents and ongoing work at Siemens Healthcare Diagnostics GmbH contribute significantly to the fight against cancer, demonstrating how dedicated inventors can impact healthcare through technology and research.